跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
WELLBUTRIN XL 300 EXTENDED RELEASE F.C.TABLET - SFDA Drug Approval Details
Approvals
/
SFDA
/
WELLBUTRIN XL 300 EXTENDED RELEASE F.C.TABLET
Authorized
NCE
WELLBUTRIN XL 300 EXTENDED RELEASE F.C.TABLET
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
5d65daa20bb092c3
Company
Unknown
Type
NCE
Approval Details
Approval Id
5d65daa20bb092c3
Drug Approval Sfda Name
WELLBUTRIN XL 300 EXTENDED RELEASE F.C.TABLET
Trade Name
WELLBUTRIN XL 300 EXTENDED RELEASE F.C.TABLET
Generic Name
BUPROPION HYDROCHLORIDE
Register Number
140-276-19
Register Year
2019
Drug Type
NCE
Route Of Administration
Oral use
Package Type
Blister
Package Size
30
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store below 30°c
Shelf Life
24 Months
Distribution Site
Pharmacy
Description Code
7000000181-300-100000116187
Price
121.05
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
5d65daa20bb092c3
Type
NCE
Back to SFDA Approvals
